News Releases
2023 NEWS RELEASES
![](https://xtacytherapeutics.com/wp-content/uploads/2023/04/WEBSITE-CARD-LOGO-300x225.jpg)
Global Wellness Strategies is Positioned to be an MDMA and Psilocybin Leader
Vancouver, British Columbia, February 6, 2023– Global Wellness Strategies Inc. (CSE:GWS) (Frankfurt:O3X4) (OTCQB: GWSFF) (“Global” or the “Company”) is positioned to become an MDMA and
![](https://xtacytherapeutics.com/wp-content/uploads/2021/11/Shanti-Featured-Image-300x157.png)
Global Wellness Strategies Updates Shanti Therapeutics Focused on MDMA Psychedelic Clinical Trials
Vancouver, British Columbia, January 31/2023: Global Wellness Strategies Inc. (CSE:GWS) (Frankfurt O3X4) (OTCQB: GWSFF) (“Global” or the “Company”) announces Shanti Therapeutics MDMA Clinical Trial Update.
![](https://xtacytherapeutics.com/wp-content/uploads/2023/04/WEBSITE-CARD-LOGO-300x225.jpg)
Global Wellness Pharma Subsidiary Supports Cancer Therapeutic Company AVM Biotechnology
Vancouver, British Columbia, December 05, 2022 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt: O3X4) (OTCQB: GWSFF) (“Global Wellness” or the “Company”) pharma subsidiary is
2022 NEWS RELEASES
![](https://xtacytherapeutics.com/wp-content/uploads/2022/05/GWS-Featured-Image-300x157.png)
Global Wellness’ Shanti Therapeutics Boosts Team with International Advisors
Vancouver, British Columbia, February 18, 2022 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt:O3X4) (OTCQB: GWSFF) (“Global” or the “Company”) today announced the addition of two
![](https://xtacytherapeutics.com/wp-content/uploads/2022/05/GWS-Featured-Image-300x157.png)
Global Wellness Strategies Signs MDMA Supply Agreement with PharmAla Biotech
Vancouver, British Columbia, February 10, 2022 – Global Wellness Strategies Inc. (CSE:GWS) (Frankfurt:O3X4) (OTCQB: GWSFF) (“Global” or the “Company”) and their Contract Research Organization(“CRO”) iNGENü (a
![](https://xtacytherapeutics.com/wp-content/uploads/2022/05/GWS-Featured-Image-300x157.png)
Global Wellness’ Shanti Therapeutics Announce Psychedelic Drug Development Agreement
Vancouver, British Columbia, January 20, 2022 – Global Wellness Strategies Inc. (CSE:GWS) (OTCQB: GWSFF) (Frankfurt:O3X4) (“Global” or the “Company”) announces that it has signed an agreement
2021 NEWS RELEASES
![](https://xtacytherapeutics.com/wp-content/uploads/2022/05/GWS-Featured-Image-300x157.png)
Global Wellness Strategies & KaleidoMyco Introduce One-Shot Drink Combining Functional Mushrooms + Hemp Extract
Vancouver, British Columbia, April 26, 2021 – Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X) (OTC QB: PNNRF) (“Global” or the “Company”) and
![](https://xtacytherapeutics.com/wp-content/uploads/2022/05/GWS-Featured-Image-300x157.png)
Global Wellness Announces KaleidoMyco Signing The Wolf of Marketing
Vancouver, British Columbia, April 14, 2021 – Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (“Global” or the “Company”) announces
![](https://xtacytherapeutics.com/wp-content/uploads/2022/05/GWS-Featured-Image-300x157.png)
Global Wellness Acquires Fast-Growing Mushroom Brand “KaleidoMyco”
Vancouver, British Columbia, April 7, 2021 – Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (“GWS” or the “Company”) signs